Skip to content
S821Senate2023-2024 SessionSame asA996

Publish Opioid Sales Data

Official title

“Relates to availability of certain reports detailing sales of opioids in this state”

Sponsor Pete HarckhamSD-40Affects Health
Status
Signed by Governor
Impact
6/10
Moderate
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill requires annual public reporting and online publication of most opioid sales data in New York, excluding purchaser details.

Why it matters

  1. Increases transparency and public oversight. by mandating that detailed opioid sales data (excluding specific purchaser information) be made available annually to the public in machine-readable formats, making it easier for researchers, journalists, and advocacy groups to analyze trends in opioid distribution.

  2. Facilitates informed policy and community response. by providing regular, accessible data that can help identify concerning patterns of opioid sales, potentially supporting more targeted public health interventions and resource allocation.

  3. Protects sensitive information. by explicitly excluding purchaser details from public reports, balancing the public’s right to know with privacy and security for healthcare providers and pharmacies.

  4. Aligns reporting requirements with digital accessibility standards. , ensuring that data isn’t just released, but is formatted in a way that allows for broad, effective use and analysis by the public and stakeholders.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Publish Opioid Sales Data

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Pete Harckham

Senator · Senate District 40

Chair, Environmental Conservation

No co-sponsors yet.

History

  1. Signed chap.76
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading rules cal.15
  6. Substituted for A996
  7. Referred to health
  8. Delivered to assembly
  9. Passed senateVote 63–0
  10. Ordered to third reading cal.30
  11. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A996Assembly

Make Opioid Sales Reports Public

Assembly Floor Calendar · Sponsor Jessica Gonzalez-Rojas

Impact 6 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

821

2023-2024 Regular Sessions

IN SENATE

January 6, 2023

Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the tax law, in relation to availability of certain reports detailing sales of opioids in this state

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision (g) of section 498 of the tax law, as amended by a chapter of the laws of 2022 amending the tax law relating to requiring the department of health to publish certain reports on department's website detailing sales of opioids sold in the state, as proposed in legislative bills numbers S. 7378-A and A. 8339-A, is amended to read as follows:

(g) Each registrant shall provide a report to the department of health detailing all opioids sold by such registrant in the state of New York. Such report shall include:

(i) the registrant's name, address, phone number, federal Drug Enforcement Agency (DEA) registration number, education department registration number, and controlled substance license number issued by the department of health, if applicable;

(ii) the name, address and DEA registration number of the entity to whom the opioid was sold;

(iii) the date of the sale of the opioid;

(iv) the gross receipt total, in dollars, for each opioid sold;

(v) the name and National Drug Code of the opioid sold;

(vi) the number of containers and the strength and metric quantity of controlled substance in each container of the opioid sold;

(vii) the total number of morphine milligram equivalents sold; and

(viii) any other elements as deemed necessary by the commissioner of health.

Such information shall be reported [and published] annually in such form as defined by the commissioner of health and shall not be subject

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03968-01-3

to the provisions of section four hundred ninety-nine of this article[, with] . With the exception of the information collected under paragraph (ii) of this subdivision[. The], the department of health shall make the information collected in such [report shall be made] reports available to the public in machine-readable formats and [such report shall be made] make it publicly available on the department of health's website annually.

§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 amending the tax law relating to requiring the department of health to publish certain reports on department's website detailing sales of opioids sold in the state, as proposed in legislative bills numbers S. 7378-A and A. 8339-A, takes effect.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the tax law, in relation to availability of certain reports detailing sales of opioids in this state

Purpose

This is a chapter amendment to chapter 771 of 2022 making technical corrections to clarify certain private data is not to be made publicly available.

Summary of provisions

Section one amends subdivision (g) of section 498 of the Tax Law to clarify that the name, address and DEA registration number of the enti- ties to whom opioids were sold to by registrants paying the opioid excise tax shall not be included in the annual reports that the Depart- ment of Health shall issue on the opioids sold in the state by regis- trants and that shall be made available to the public and posted annual- ly in the department's website.

Section 2 is the effective date.

Existing law

None.

Justification

This legislation is a negotiated change to the underlying chapter.

Legislative history

Chapter amendment to Chapter 771 of the Laws of 2022. S.7378-A passed the Senate in April 2022, and A.8339-A passed the Assembly in May 2022.

Fiscal implications

None

Effective date

This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 amending the tax law relating to requiring the department of health to publish certain reports on department's website detailing sales of opioids sold in the state, as proposed in legislative bills numbers S. 7378-A and A. 8339-A, takes effect.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.